Hsbc Holdings PLC Takes $1.69 Million Position in Cabot Corporation $CBT

Hsbc Holdings PLC purchased a new position in Cabot Corporation (NYSE:CBT) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 18,575 shares of the specialty chemicals company’s stock, valued at approximately $1,690,000.

Other hedge funds also recently bought and sold shares of the company. NewEdge Advisors LLC increased its holdings in shares of Cabot by 2,559.5% in the 1st quarter. NewEdge Advisors LLC now owns 984 shares of the specialty chemicals company’s stock worth $82,000 after buying an additional 947 shares during the last quarter. Goldman Sachs Group Inc. lifted its holdings in shares of Cabot by 32.5% in the 1st quarter. Goldman Sachs Group Inc. now owns 442,646 shares of the specialty chemicals company’s stock valued at $36,802,000 after acquiring an additional 108,645 shares during the last quarter. Empowered Funds LLC grew its position in Cabot by 102.6% in the first quarter. Empowered Funds LLC now owns 28,162 shares of the specialty chemicals company’s stock worth $2,341,000 after acquiring an additional 14,260 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its position in Cabot by 3.4% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 122,022 shares of the specialty chemicals company’s stock worth $10,145,000 after acquiring an additional 4,048 shares in the last quarter. Finally, Geneos Wealth Management Inc. increased its stake in Cabot by 409.0% during the first quarter. Geneos Wealth Management Inc. now owns 453 shares of the specialty chemicals company’s stock worth $38,000 after acquiring an additional 364 shares during the last quarter. Hedge funds and other institutional investors own 93.18% of the company’s stock.

Insider Activity

In related news, CEO Sean D. Keohane sold 2,779 shares of the stock in a transaction that occurred on Monday, August 24th. The stock was sold at an average price of $85.50, for a total value of $237,604.50. Following the transaction, the chief executive officer owned 288,873 shares of the company’s stock, valued at $24,698,641.50. This represents a 0.95% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 3.08% of the company’s stock.

Cabot Stock Up 0.0%

Shares of CBT opened at $83.67 on Monday. The firm has a fifty day moving average price of $87.62 and a 200-day moving average price of $81.24. The company has a current ratio of 1.47, a quick ratio of 0.97 and a debt-to-equity ratio of 0.48. The firm has a market capitalization of $4.32 billion, a P/E ratio of 23.57, a P/E/G ratio of 10.98 and a beta of 0.84. Cabot Corporation has a 12-month low of $58.33 and a 12-month high of $94.53.

Cabot (NYSE:CBT) last announced its quarterly earnings data on Monday, August 3rd. The specialty chemicals company reported $1.67 earnings per share for the quarter, beating analysts’ consensus estimates of $1.66 by $0.01. The company had revenue of $982.00 million during the quarter, compared to analyst estimates of $943.16 million. Cabot had a net margin of 5.23% and a return on equity of 20.29%. The firm’s revenue for the quarter was up 6.4% on a year-over-year basis. During the same quarter last year, the business posted $1.90 EPS. Cabot has set its FY 2026 guidance at 6.150-6.450 EPS. Equities research analysts expect that Cabot Corporation will post 6.35 earnings per share for the current year.

Cabot Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, September 11th. Stockholders of record on Friday, August 28th will be paid a dividend of $0.4725 per share. This represents a $1.89 annualized dividend and a dividend yield of 2.3%. The ex-dividend date of this dividend is Friday, August 28th. Cabot’s payout ratio is currently 53.24%.

Analyst Ratings Changes

Several equities research analysts have recently issued reports on the company. Wall Street Zen raised Cabot from a “hold” rating to a “buy” rating in a research note on Sunday, August 9th. Mizuho increased their price target on Cabot from $80.00 to $90.00 and gave the company a “neutral” rating in a report on Thursday, June 25th. Truist Financial set a $100.00 price target on Cabot in a research report on Wednesday, August 5th. UBS Group dropped their price objective on shares of Cabot from $97.00 to $92.00 and set a “neutral” rating for the company in a research note on Wednesday, August 5th. Finally, Weiss Ratings reiterated a “hold (c)” rating on shares of Cabot in a research report on Friday, August 21st. Two equities research analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of $89.00.

Cabot Company Profile

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.